- Home
- CRESY vs SAGE Comparison
CRESY vs SAGE Comparison
Compare CRESY & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRESY
- SAGE
- Stock Information
- Founded
- CRESY 1936
- SAGE 2010
- Country
- CRESY Argentina
- SAGE United States
- Employees
- CRESY N/A
- SAGE N/A
- Industry
- CRESY Real Estate
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- CRESY Finance
- SAGE Health Care
- Exchange
- CRESY Nasdaq
- SAGE Nasdaq
- Market Cap
- CRESY 568.6M
- SAGE 462.2M
- IPO Year
- CRESY 1997
- SAGE 2014
- Fundamental
- Price
- CRESY $10.81
- SAGE $5.10
- Analyst Decision
- CRESY
- SAGE Hold
- Analyst Count
- CRESY 0
- SAGE 20
- Target Price
- CRESY N/A
- SAGE $12.89
- AVG Volume (30 Days)
- CRESY 229.2K
- SAGE 822.5K
- Earning Date
- CRESY 11-08-2024
- SAGE 10-29-2024
- Dividend Yield
- CRESY 6.91%
- SAGE N/A
- EPS Growth
- CRESY N/A
- SAGE N/A
- EPS
- CRESY N/A
- SAGE N/A
- Revenue
- CRESY $751,941,316.00
- SAGE $106,399,000.00
- Revenue This Year
- CRESY N/A
- SAGE N/A
- Revenue Next Year
- CRESY N/A
- SAGE $118.26
- P/E Ratio
- CRESY N/A
- SAGE N/A
- Revenue Growth
- CRESY 294.53
- SAGE 837.60
- 52 Week Low
- CRESY $6.56
- SAGE $5.03
- 52 Week High
- CRESY $11.32
- SAGE $28.26
- Technical
- Relative Strength Index (RSI)
- CRESY 70.98
- SAGE 28.88
- Support Level
- CRESY $9.76
- SAGE $5.86
- Resistance Level
- CRESY $10.36
- SAGE $5.87
- Average True Range (ATR)
- CRESY 0.52
- SAGE 0.51
- MACD
- CRESY 0.12
- SAGE -0.14
- Stochastic Oscillator
- CRESY 78.02
- SAGE 1.91
About CRESY Cresud S.A.C.I.F. y A.
Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.